Kinoxis Therapeutics
Melbourne
About Kinoxis Therapeutics
Kinoxis Therapeutics is an early stage biotechnology company based in Australia that is working to progress the development of a range of novel therapeutic compounds for the treatment of substance use disorders and other CNS conditions. The company has licensed these compounds from the University of Sydney, with the lead candidate demonstrating potent anti-addictive and prosocial effects in a number of different animal models and is progressing through pre-clinical testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $22.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2024)
- Website: kinoxistherapeutics.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/kinoxis-therapeutics-62671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.